BRCA1 and breast cancer: While this approach might limit the number of potential candidate variants detected as compared to other less stringent family selection strategies [32], it is a reflection of the small number of non-BRCA1/2 families presenting a high number (from 6 to 10) of BC events per family, which in turn represents a highly desirable starting point for the identification of novel high penetrance genes in any disease.